Dafloxacin is a broad-spectrum bactericide. It has strong antibacterial activity against Pasteurella, Mycoplasma and Escherichia coli. Danofloxacin is a synthetic fluoroquinolone with broad spectrum antibacterial activity. It is used in the treatment of respiratory disease in chickens, cattle and pigs.
Increasing research and development activities for enhancing the efficiency of Dafloxacin in treating respiratory diseases in animals and humans is a major factor boosting growth of the Dafloxacin market.
The global Danofloxacin (CAS 112398-08-0) market is segregated on the basis of Type as 95% Purity Type, 98% Purity Type, 99% Purity Type, and Others. Based on Application the global Danofloxacin (CAS 112398-08-0) market is segmented in Dafloxacin Mesylate Injection and Dafloxacin Mesylate Powder.
The global Danofloxacin (CAS 112398-08-0) market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Danofloxacin (CAS 112398-08-0) market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Zhenglong Animal Pharm, Zoetis, AdvaCare Pharma, Hebao Biotechnology, Suzhou Laijin Bioscience, Anrui Bioscience, Zhuhai Xuanyi Pharm, and others are among the major players in the global Danofloxacin (CAS 112398-08-0) market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Danofloxacin (CAS 112398-08-0) Market has been segmented as below:
Danofloxacin (CAS 112398-08-0) Market, By Type
Danofloxacin (CAS 112398-08-0) Market, By Application
Danofloxacin (CAS 112398-08-0) Market, By Region
Danofloxacin (CAS 112398-08-0) Market, By Company
The report covers:
Report Scope:
The global Danofloxacin (CAS 112398-08-0) market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Danofloxacin (CAS 112398-08-0) market share. Major industry players with significant revenue share include Zhenglong Animal Pharm, Zoetis, AdvaCare Pharma, Hebao Biotechnology, Suzhou Laijin Bioscience, Anrui Bioscience, Zhuhai Xuanyi Pharm, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
women’s health therapeutics market
xerostomia therapeutics market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Danofloxacin (CAS 112398-08-0) Market, By Type
5.1 Introduction
5.2 95% Purity Type
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 98% Purity Type
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 99% Purity Type
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Others
5.5.1 Market Overview
5.5.2 Market Size and Forecast
6. Danofloxacin (CAS 112398-08-0) Market, By Application
6.1 Introduction
6.2 Dafloxacin Mesylate Injection
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Dafloxacin Mesylate Powder
6.3.1 Market Overview
6.3.2 Market Size and Forecast
7. Danofloxacin (CAS 112398-08-0) Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America Danofloxacin (CAS 112398-08-0), By Type
7.2.2 North America Danofloxacin (CAS 112398-08-0), By Application
7.3 Europe
7.3.1 Europe Danofloxacin (CAS 112398-08-0), By Type
7.3.2 Europe Danofloxacin (CAS 112398-08-0), By Application
7.4 Asia-Pacific
7.4.1 Asia-Pacific Danofloxacin (CAS 112398-08-0), By Type
7.4.2 Asia-Pacific Danofloxacin (CAS 112398-08-0), By Application
7.5 Rest of the World
7.5.1 Rest of the World Danofloxacin (CAS 112398-08-0), By Type
7.5.2 Rest of the World Danofloxacin (CAS 112398-08-0), By Application
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
9.1 Zhenglong Animal Pharm
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 Zoetis
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 AdvaCare Pharma
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Hebao Biotechnology
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Suzhou Laijin Bioscience
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Anrui Bioscience
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Zhuhai Xuanyi Pharm
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
The Danofloxacin (CAS 112398-08-0) Market has been segmented as below:
Danofloxacin (CAS 112398-08-0) Market, By Type
Danofloxacin (CAS 112398-08-0) Market, By Application
Danofloxacin (CAS 112398-08-0) Market, By Region
Danofloxacin (CAS 112398-08-0) Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
